blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3958881

EP3958881 - ABCB5+ STEM CELL THERAPEUTICS FOR LIVER DISEASE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.11.2023
Database last updated on 15.07.2024
FormerRequest for examination was made
Status updated on  28.01.2022
FormerThe international publication has been made
Status updated on  31.10.2020
Most recent event   Tooltip24.11.2023Application deemed to be withdrawnpublished on 27.12.2023  [2023/52]
Applicant(s)For all designated states
Children's Medical Center Corporation
55 Shattuck Street
Boston, MA 02115 / US
For all designated states
Ticeba GmbH
Im Neuenheimer Feld 517
69120 Heidelberg / DE
[2022/09]
Inventor(s)01 / FRANK, Markus, H.
9 Brewer Street
Cambridge, MA 02138 / US
02 / GANSS, Christoph
c/o TICEBA GmbH
Tissue and Cell Banking
Im Neuenheimer Feld 517
69120 Heidelberg / DE
03 / KLUTH, Mark Andreas
c/o TICEBA GmbH
Tissue and Cell Banking
Im Neuenheimer Feld 517
69120 Heidelberg / DE
 [2022/09]
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2022/09]Potter Clarkson
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Application number, filing date20795305.024.04.2020
[2022/09]
WO2020US29833
Priority number, dateUS201962838062P24.04.2019         Original published format: US 201962838062 P
[2022/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020219895
Date:29.10.2020
Language:EN
[2020/44]
Type: A1 Application with search report 
No.:EP3958881
Date:02.03.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 29.10.2020 takes the place of the publication of the European patent application.
[2022/09]
Search report(s)International search report - published on:AU29.10.2020
(Supplementary) European search report - dispatched on:EP20.12.2022
ClassificationIPC:A61K35/545, C12N5/0797, A61P1/16
[2022/09]
CPC:
A61P1/16 (EP,AU,US); A61K35/28 (EP,AU,US); A61K9/0019 (EP,AU,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/09]
TitleGerman:ABCB5+-STAMMZELLTHERAPEUTIKA FÜR LEBERERKRANKUNGEN[2022/09]
English:ABCB5+ STEM CELL THERAPEUTICS FOR LIVER DISEASE[2022/09]
French:AGENTS THÉRAPEUTIQUES À CELLULES SOUCHES ABCB5+ CONTRE UNE MALADIE HÉPATIQUE[2022/09]
Entry into regional phase02.11.2021National basic fee paid 
02.11.2021Search fee paid 
02.11.2021Designation fee(s) paid 
02.11.2021Examination fee paid 
Examination procedure02.11.2021Examination requested  [2022/09]
27.06.2022Amendment by applicant (claims and/or description)
22.07.2023Application deemed to be withdrawn, date of legal effect  [2023/52]
11.08.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2023/52]
Fees paidRenewal fee
27.04.2022Renewal fee patent year 03
27.04.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[X]WO2007143139  (BRIGHAM & WOMENS HOSPITAL [US], et al) [X] 1-11 * pg 8 Ins 8-15; pg 9 Ins 8-31; pg 22 Ins 7-31, pg 10 Ins 24-28, pg 3 Ins 17-20; pg 4 Ins 22-29; pg 15 Ins 16-30; claims 15, 26, 27 and 45 *;
 [X]WO2014182994  (CHILDRENS MEDICAL CENTER [US], et al) [X] 1-11* pg 2 Ins 24-26; pg 4 Ins 17-21; pg 13 Ins 4-14; pg 8 Ins 14-31; pg 9 Ins 1-3, 16-18, 26-31; pg 11 Ins 1-8; pg 32 Ins 29-32; claims 30, 31, 33 and 34; pg 19 In 1-pg 20 In 7; pg 24 Ins 3-32 *;
 [X]  - TIETZE, L et al., "Assessment of the hepatocytic differentiation ability of human skin- derived ABCB5+ stem cells", Experimental Cell Research, (20180000), vol. 369, doi:10.1016/j.yexcr.2018.05.040, pages 335 - 347, XP085432995 [X] 1-11 * Abstract, paras 2.1, 2.9, end of 3.2, 3.3, 3.4, 4.2 and 4.3 *

DOI:   http://dx.doi.org/10.1016/j.yexcr.2018.05.040
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.